Respiratory infections in adults hospitalized in internal medicine and pneumology departments. DIRA study;Estudio de las infecciones respiratorias en el adulto ingresado en servicios de medicina interna y neumología. Estudio DIRA

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 21, Issue 4, 2003, Pages 180-187

  Picazo, Juan J ^a   Pérez Cecilia, Elisa ^a   Herreras, Amadeo ^b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

Author keywords

Acute Bronchitis; Pneumonia; Recurrent COPD; Respiratory infection

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; PENICILLIN G; QUINOLONE DERIVATIVE;

ADULT; AGED; ARTICLE; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DISEASE PREDISPOSITION; FEMALE; HOSPITALIZATION; HUMAN; INTERNAL MEDICINE; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PREVALENCE; RESPIRATORY TRACT INFECTION; UPPER RESPIRATORY TRACT INFECTION;

EID: 0344951010     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13045448     Document Type: Article

References (48)

1. Picazo JJ, Pérez-Cecilia E. Epidemiologia de la infección respiratoria en España. Enferm Infecc Microbiol Clin 1999;17(Suppl 1):3-7.
2. Romero Vivas J, Rubio Alonso M, Corral O, Pacheco S, Agudo E, Picazo JJ. Estudio de las infecciones respiratorias extrahospitalarias. Enferm Infecc Microbiol Clin 1997;15:289-98.
3. Grupo de trabajo EPINE. Evolución de la prevalencia de las infecciones nosocomiales en los hospitales españoles. En: Vaqué J, Roselló J, editors. EPINE 1990-1999 Sociedad Española de Medicina Preventiva, Salud Pública e Higiene; 2001.
4. Dinkel RH, Lebok U. A survey of nosocomial infections and their influence on hospital mortality rates. J Hosp Infect 1994;28:297-304.
5. Peña C, Pujol M, Pallarés R, Corbella X, Vidal T, Tortras N, et al. Estimación del coste atribuible a la infección nosocomial: prolongación de la estancia hospitalaria y cálculo de costes alternativos. Med Clin (Barc) 1996;106:441-4.
6. Torres A, Serra-Batlles J, Ferrer A, Jiménez P, Celis R, Cobo E, et al. Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis 1991;144:312-8.
7. Feldman C, Ross S, Mahomed AG, Omar J, Smith C. The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy. Respir Med 1995;89:187-92.
8. Vaqué J, Rosselló J, Arribas JL. Prevalence of nosocomial infections in Spain: EPINE study 1990-1997. EPINE Working Group. J Hosp Infect 1999;43(Suppl):S105-S11.
9. Saviteer SM, Samsa GP, Rutala WA. Nosocomial infections in the elderly. Increased risk per hospital day. Am J Med 1988;84:661-6.
10. Rello J, Ausina V, Ricart M, Puzo C, Net A, Prats G. Nosocomial pneumonia in critically ill comatose patients: Need for a differential therapeutic approach. Eur Respir J 1992;5:1249-53.
11. González C, Rubio M, Romero-Vivas J, González M, Picazo JJ. Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 1999;29:1171-7.
12. Fine MJ, Smith DN, Singer DE. Hospitalization decision in patients with community-acquired pneumonia: A prospective cohort study. Am J Med 1990;89:713-21.
13. Fine MJ, Singer DE, Hanusa BH, Lave JR, Kapoor WN. Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database. Am J Med 1993;94:153-9.
14. Marcucci GJ, Sánchez P, Magnelli FP, Carena J. Neumonías adquiridas en la comunidad. Criterios de hospitalización e indicadores de curso complicado. Medicina (Buenos Aires) 1995;55:641-6.
15. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
16. Zalacaín R, Talayero N, Achotegui V, Corral J, Barrena I, Sobradillo V. Neumonía adquirida en la comunidad. Fiabilidad de los criterios para decidir tratamiento ambulatorio. Arch Bronconeumol 1997;33:74-9.
17. Gravil JH, Al-Rawas OA, Cotton MM, Flanigan U, Irwin A, Stevenson RD. Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service. Lancet 1998;351:1853-5.
18. Metlay JP, Schulz R, Li YH, Singer DE, Marrie TJ, Coley CM, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 1997;157:1453-9.
19. Carr B, Walsh JB, Coakley D, Mulvihill E, Keane C. Prospective hospital study of community acquired lower respiratory tract infection in the elderly. Respir Med 1991;85:185-7.
20. Rello J, Rodríguez R, Jubert P, Álvarez B. Severe community-acquired pneumonia in the elderly: Epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia. Clin Infect Dis 1996;23:723-8.
21. Brancati FL, Chow JW, Wagener MM, Vacarello SJ, Yu VL. Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia. Lancet 1993;342:30-3.
22. Segado Soriano A, López González-Cobos C, Montés Germán I, Pinilla Llorente B, García Castaño J, Muiño Miguez A. Factores pronósticos de mortalidad en la neumonía comunitaria que requiere hospitalización. Rev Clin Esp 1994;194:276-81.
23. Leroy O, Santré C, Beuscart C, Georges H, Guery B, Jacquier JM, et al. A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 1995;21:24-31.
24. Grupo DAFNE. Estudio farmacoeconómico del tratamiento antibiótico de las agudizaciones de la bronquitis crónica en atención primaria. Grupo DAFNE. Aten Primaria 2000;25:153-9.
25. Miravitlles M, Guerrero T, Mayordomo C, Sánchez-Agudo L, Nicolau F, Segu JL. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: A multiple logistic regression analysis. The EOLO Study Group. Respiration 2000;67:495-501.
26. Black ER, Mushlin AI, Griner PF, Suchman AL, James RL Jr, Schoch DR. Predicting the need for hospitalization of ambulatory patients with pneumonia. J Gen Intern Med 1991;6:394-400.
27. Lange P, Vestbo J, Nyboe J. Risk factors for death and hospitalization from pneumonia. A prospective study of a general population. Eur Respir J 1995;8:1694-8.
28. Neill AM, Martin IR, Weir R, Anderson R, Chereshsky A, Epton MJ, et al. Community acquired pneumonia: Aetiology and usefulness of severity criteria on admission. Thorax 1996;51:1010-6.
29. Atlas SJ, Benzer TI, Borowsky LH, Chang Y, Burnham DC, Metlay JP, et al. Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: An interventional trial. Arch Intern Med 1998;158:1350-6.
30. Ruiz A, Vallverdd M, Falguera M, Pérez J, Cabré X, Almirall M, et al. Neumonía adquirida en la comunidad: impacto de la utilización de una estrategia terapéutica basada en la mortalidad a corto plazo. Med Clin (Barc) 1999;113:85-8.
31. Hasnain M, Clark EJ. Management strategies for community acquired pneumonia. J Med Syst 2000;24:279-88.
32. Boersma WG. Assessment of severity of community-acquired pneumonia. Semin Respir Infect 1999;14:103-14.
33. Halls GA. The management of infections and antibiotic therapy: A European survey. J Antimicrob Chemother 1993;31:985-1000.
34. Porath A, Schlaeffer F, Lieberman D. The epidemiology of community-acquired pneumonia among hospitalized adults. J Infect 1997;34:41-8.
35. Daifuku R, Movahhed H, Fotheringham N, Bear MB, Nelson S. Time to resolution of morbidity: An endpoint for assessing the clinical cure of community-acquired pneumonia. Respir Med 1996;90:587-92.
36. Hedlund JU, Ortqvist AB, Kalin ME, Granath F. Factors of importance for the long term prognosis after hospital treated pneumonia. Thorax 1993;48:785-9.
37. Hedlund J. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis. Scand J Infect Dis 1995;97(Suppl):1-60.
38. Weingarten SR, Riedinger MS, Varis G, Noah MS, Belman MJ, Meyer RD, et al. Identification of low-risk hospitalized patients with pneumonia. Implications for early conversion to oral antimicrobial therapy. Chest 1994;105:1109-15.
39. Chan R, Hemeryck L, O'Regan M, Clancy L, Feely J. Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: Open, randomised controlled trial. BMJ 1995;310:1360-2.
40. Coley CM, Li YH, Medsger AR, Marrie TJ, Fine MJ, Kapoor WN, et al. Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia. Arch Intern Med 1996;156:1565-71.
41. Guest JF, Morris A. Community-acquired pneumonia: The annual cost to the National Health Service in the UK. Eur Respir J 1997;10:1530-4.
42. Ramírez JA. Switch therapy in community-acquired pneumonia. Diagn Microbiol Infect Dis 1995;22:219-23.
43. Weingarten SR, Riedinger MS, Hobson P, Noah MS, Johnson B, Giugliano G, et al. Evaluation of a pneumonia practice guideline in an interventional trial. Am J Respir Crit Care Med 1996;153:1110-5.
44. Ruiz Manzano J, Fernández Martínez P, Morera J, Prats MS, Rosell A, Andreo F. Infección y uso de antibióticos en la EPOC en atención primaria. Arch Bronconeumol 2000;36:326-33.
45. Postma DS. When can an exacerbation of COPD be treated at home? Lancet 1998;351:1827-8.
46. Gonzales R, Bartlett JG, Besser RE, Cooper RJ, Hickner JM, Hoffman JR, et al. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Emerg Med 2001;37:690-7.
47. Ochoa C, Eiros JM, Inglada L, Vallano A, Guerra L. Assessment of antibiotic prescription in acute respiratory infections in adults. The Spanish Study Group on Antibiotic Treatments. J Infect 2000;41:73-83.
48. Huchon GJ, Gialdroni-Grassi G, Leophonte P, Manresa F, Schaberg T, Woodhead M. Initial antibiotic therapy for lower respiratory tract infection in the community: A European survey. Eur Respir J 1996;9:1590-5.